CALCA and familial pancreatic carcinoma: Next, we asked if API’s immunomodulatory ability occurred in another clinically relevant model of PC (designated KrasG12D; Pdx1-Cre (KC)-HPC mice), making use of a novel pancreatic cancer cell line that mimics human PC due to its expression of mutated Kras [40].